Russell Investments Group
RLMD icon

Russell Investments Group’s Relmada Therapeutics RLMD Stock Holding History

Russell Investments Group’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.3K Buy
+7,562
New +$52.8K ﹤0.01% 3613
2024
Q3 		– Sell
-53
Closed -$159 – 3780
2024
Q2 		$159 Buy
+53
New +$192 ﹤0.01% 3557
2024
Q1 		– Sell
-53
Closed -$219 – 3358
2023
Q4 		$219 Hold
53
– – ﹤0.01% 3176
2023
Q3 		$159 Hold
53
– – ﹤0.01% 3505
2023
Q2 		$130 Sell
53
-60
-53% -$166 ﹤0.01% 3433
2023
Q1 		$255 Buy
+113
New +$390 ﹤0.01% 3254

Other funds holding RLMD

Jupiter Topco
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Russell Investments Group's RLMD Position: Q2 2026 in Review

Russell Investments Group opened a new position in Relmada Therapeutics (RLMD) in Q2 2026: 7,562 shares worth $52.3K. The stake represents ﹤0.01% of the portfolio and ranks #3613 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in RLMD as recently as Q2 2024.

Russell Investments Group first reported a position in RLMD in Q1 2023 and has held it in 6 quarters since. 126 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

  • Russell Investments Group held 7,562 shares of Relmada Therapeutics worth $52.3K as of Q2 2026.
  • Relmada Therapeutics was a new Russell Investments Group position in Q2 2026.
  • Relmada Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3613 holding.
  • Russell Investments Group first reported a position in Relmada Therapeutics in Q1 2023 and has held it in 6 quarters since.
  • 126 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.